Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases.
- Authors
- de Klein, Niek; Tsai, Ellen A; Vochteloo, Martijn; Baird, Denis; Huang, Yunfeng; Chen, Chia-Yen; van Dam, Sipko; Oelen, Roy; Deelen, Patrick; Bakker, Olivier B; El Garwany, Omar; Ouyang, Zhengyu; Marshall, Eric E; Zavodszky, Maria I; van Rheenen, Wouter; Bakker, Mark K; Veldink, Jan; Gaunt, Tom R; Runz, Heiko; Franke, Lude; Westra, Harm-Jan
- Year
- 2023
- Journal
- Nature genetics
- PMID
- 36823318
- DOI
- 10.1038/s41588-023-01300-6
- PMCID
- PMC10011140
Identification of therapeutic targets from genome-wide association studies (GWAS) requires insights into downstream functional consequences. We harmonized 8,613 RNA-sequencing samples from 14 brain datasets to create the MetaBrain resource and performed cis- and trans-expression quantitative trait locus (eQTL) meta-analyses in multiple brain region- and ancestry-specific datasets (nββ€β2,759). Many of the 16,169 cortex cis-eQTLs were tissue-dependent when compared with blood cis-eQTLs. We inferred brain cell types for 3,549 cis-eQTLs by interaction analysis. We prioritized 186 cis-eQTLs for 31 brain-related traits using Mendelian randomization and co-localization including 40 cis-eQTLs with an inferred cell type, such as a neuron-specific cis-eQTL (CYP24A1) for multiple sclerosis. We further describe 737 trans-eQTLs for 526 unique variants and 108 unique genes. We used brain-specific gene-co-regulation networks to link GWAS loci and prioritize additional genes for five central nervous system diseases. This study represents a valuable resource for post-GWAS research on central nervous system diseases.
Overview of the study.We downloaded publicly available RNA-seq and genotype data from 14 different datasets consisting of 8,613 RNA-seq measurements from seven main brain regions and 6,518 genotype samples. We created six eQTL meta-analysis datasets and performed cis-, trans- and interaction-eQTL analyses, built a brain-specific gene co-regulation network and prioritized genes using MR, co-localization and the co-regulation network. Image of sagittal cut of brain created with BioRender.com. This figure summarizes values from Supplementary Tables 1, 3, 8, 12 and 25β30.
Overview of the datasets.a, Number of samples per included cohort stratified according to the seven major brain regions. b, PCA dimensionality reduction plot of the normalized expression data after covariate correction. Each dot represents an RNA-seq sample and is colored according to the brain region. The figure shows that the samples cluster mainly on the brain region. c, Number of genotypes per cohort stratified according to ancestry. AMR, Admixed Americans; SAS, South Asian. d, Number of individuals per cohort, with each color representing an eQTL dataset. The number of individuals differ from the intersection between the number of RNA-seq samples and number of genotypes because not all samples with genotypes have RNA-seq samples and vice versa, and some individuals with genotypes have multiple RNA-seq measurements.Source data
Conditional cis-eQTLs.a, Number of conditional cis-eQTLs per eQTL dataset. b, Comparison of characteristics between primary and non-primary eQTLs. For the mean expression and pLI score values, each row compares the eQTL genes for that rank with eQTL genes from the previous rank (for example, for tertiary eQTLs, the non-significant (grey) distribution is from genes that have secondary but lack tertiary eQTLs). P values were calculated using a Wilcoxon test between significant and non-significant genes. Differences in mean gene expression levels (left), the distance between the most significant SNPβgene combination and the TSS (middle), and pLI scores (right) are shown. For primary, secondary and quaternary eQTLs, non-significant eQTLs have higher pLI scores. Vertical dotted lines indicate median of the distribution for the current rank (coloured) versus the previous rank (black). c,d, Number of overlapping eQTLs along with the Rb and standard error (s.e.) values of primary cis-eQTLs between the cortex eQTLs of different ancestries (c) and the different brain regions for the EUR datasets (d). n, sample size of the dataset. e, Correlation of effect sizes and standard error of primary cis-eQTLs of Cortex-EUR (discovery, excluding GTEx) in all of the GTEx tissues (replication). Each dot is a different GTEx tissue; the x axis indicates the number of eQTLs that are significant in both discovery and replication.Source data
Cell-type ieQTLs.a, Pearsonβs correlations between the seven predicted cell-count proportions within cortex samples. b, Predicted cell-type proportions compared with cell-type proportions measured using IHC for 42 ROSMAP samples. Pearsonβs correlation coefficients are provided. The cell-count predictions for most cell types closely approximate actual IHC cell counts. Shaded areas around regression lines indicate 95% confidence interval. c, Number of cell-type ieQTLs for Cortex-EUR deconvoluted cell types. The first 20 intersections with the highest overlap are shown. Oligodendrocytes have the most interactions, followed by astrocytes and other neurons. Notably, most interactions are unique for one cell type in 87.1% of the cases. dβf, Replication of cell-type ieQTLs for STMN4 (d), FAM221A (e) and CD38 (f), consisting of the scatterplot of the cell-type ieQTL in MetaBrain Cortex-EUR bulk RNA-seq (left) and a forest plot for the eQTL effect in the ROSMAP snRNA-seq data (right). Each dot in the scatterplots (left) represents a sample; colors indicate SNP genotype, with yellow being the minor allele; values under the genotypes are the Pearsonβs correlation coefficients; interaction P values were determined using a one-sided F-test; eQTL P values were derived using the standard normal distribution from meta-analyzed z-scores. Forest plot (right): eQTL Ξ² values (dots) and standard error (error bars) with effect direction relative to the minor allele when replicating the eQTL effect in ROSMAP single-nucleus data (n = 38); each row denotes a cell type-specific dataset; cell types highlighted in bold reflect the equivalent to the cell type used in the ieQTL. Vertical dashed lines indicate an eQTL beta of 0. TMM, trimmed mean of M-values; AST, astrocytes; END, endothelial cells; EX, excitatory neurons; IN, inhibitory neurons; MIC, microglia; OPC, oligodendrocyte precursor cells; OLI, oligodendrocytes; NEU, other neuron; PER, pericytes.Source data
Co-localization and MR analysis of brain-related traits.a, Number of significant Wald ratio effects (blue) and those with both Wald ratio and co-localization (coloc; red) evidence for 13 brain-related traits. b, Forest plots showing the SNP and effect allele (EA), eQTL Ξ² and GWAS odds ratio for 20 MS-associated genes that are both MR and co-localization significant as well as their Wald ratio P value. The dots indicate the eQTL Ξ² or odds ratio, the error bars indicate the 95% confidence interval. WR, Wald ratio; and OR, odds ratio. Grey dotted line indicates an OR of 1. c,d, Cell-type ieQTL for CYP24A1 (c) and CLECL1 (d) showing interactions with predicted excitatory neuron and microglia proportions, respectively. Each dot represents a sample. Colors indicate the SNP genotype, with yellow being the minor allele. Values under the alleles are the Pearsonβs correlation coefficients. Interaction P values were derived using a one-sided F-test; eQTL P values were derived using the standard normal distribution from meta-analyzed z-scores. TMM, trimmed mean of M-values.Source data
Trans-eQTLs in the brain.a, Location of the identified trans-eQTLs (SNP and gene positions) in the genome. The size of the dots indicates the P value of the trans-eQTL (larger is more significant). b, Two examples of convergent effects, where multiple independent SNPs affect the same genes in trans. Trans-eQTLs of rs1427407 and rs4895441 on HBG2 (top). Trans-eQTL of rs1150668 and rs106871 on ZNF31 and S100A5 (bottom). Both panels are derived from Supplementary Table 17.
Gene co-regulation.a, Genes that are co-regulated with genes that are within ALS-associated loci. Co-regulation scores between genes were calculated using the MetaBrain cerebellum and MetaBrain cortex samples as well as the combined (all) MetaBrain samples. Except for URB4, cortex and cerebellum networks find different co-regulated genes for ALS. b, Co-regulation network using all MetaBrain samples for all genes prioritized for ALS by Downstreamer. c, Top five Human Phenotype Ontology (HPO) enrichments for the Downstreamer prioritized ALS-associated genes. d, Genes that are co-regulated with genes that are within MS-associated loci. Co-regulation scores between genes were calculated using a heterogeneous multi-tissue network, MetaBrain cerebellum samples and MetaBrain cortex samples. Most genes were found using a large heterogenous co-regulation network. e, Co-regulation network of all MetaBrain samples for 33 genes prioritized by Downstreamer in cortex. f, Top five Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichments for the Downstreamer prioritized MS genes in the cortex highlight neurotrophin signaling pathway enrichment (red). c,f, Enrichment P values were calculated using a two-sided Ο2 test. Panels a and d are derived from Supplementary Tables 25, 29 and 30.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. | 2025 | 40360802 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A meta-analysis of single-nucleus expression quantitative trait loci linking genetic risk to brain disorders. | Jang B et al. | β | 2026 | β |
| CARDBiomedBench: a benchmark for evaluating the performance of large language models in biomedical research. | Bianchi O et al. | β | 2026 | β |
| CRISPRi screening in cultured human astrocytes uncovers distal enhancers controlling genes dysregulated in Alzheimer's disease. | Green NFO et al. | β | 2026 | β |
| Gene-Environment Interaction of Rims1 and Adolescent Social Isolation on Schizophrenia-Like Behaviors in Mice. | Lin LH et al. | β | 2026 | β |
| Genetic evidence that FGF21 signaling reduces problematic alcohol use and alcohol-related liver disease. | Rosoff DB et al. | β | 2026 | β |
| Higher eQTL power reveals signals that boost GWAS colocalization. | Rosen JD et al. | β | 2026 | β |
| Identification of SENP7 and UTF1/VENTX as new loci influencing clustered protocadherin methylation across blood and brain using a genome-wide association study. | Liu Y et al. | β | 2026 | β |
| In Vivo Screen of Parkinson's Disease GWAS Risk Genes Identifies <i>ARIH2</i> as a Novel Regulator of Ξ±-Synuclein Toxicity in Dopaminergic Neurons. | Armakola M et al. | β | 2026 | β |
| Mendelian randomization study of GLP-1R effects on ovarian cancer subtypes mediated by metabolic factors. | Liu J et al. | β | 2026 | β |
| Multi-omics analysis reveals CXCL14<sup>+</sup> inhibitory neuron dysfunction in major depressive disorder. | Zhang L et al. | β | 2026 | β |
| Single-cell eQTL mapping reveals cell-type-specific genetic regulation in lung cancer. | Fu Y et al. | β | 2026 | β |
| Single-cell expression QTL analyses of the human cerebellum reveal vulnerability of oligodendrocytes in essential tremor. | Castonguay CE et al. | β | 2026 | β |
| The genetics of multiple sclerosis: an updated perspective. | Bellucci G et al. | β | 2026 | β |
| Understanding Neurodegenerative Diseases From the -Omics Perspective: Lessons Learnt. | Ibanez L et al. | β | 2026 | β |
| A genome-wide association study of European advanced cancer patients treated with opioids identifies regulatory variants on chromosome 20 associated with pain intensity. | Minnai F et al. | β | 2025 | β |
| A multivariable cis-Mendelian randomization method robust to weak instrument bias and horizontal pleiotropy bias. | Yang Y et al. | β | 2025 | β |
| An atlas of single-cell eQTLs dissects autoimmune disease genes and identifies novel drug classes for treatment. | Wang L et al. | β | 2025 | β |
| A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease. | Dou L et al. | β | 2025 | β |
| A panoramic view of cotton resistance to <i>Verticillium dahliae</i>: From genetic architectures to precision genomic selection. | Zhang X et al. | β | 2025 | β |
| Biomarker identification for Alzheimer's disease through integration of comprehensive Mendelian randomization and proteomics data. | Zhan H et al. | β | 2025 | β |
| Brain and blood transcriptome-wide association studies identify five novel genes associated with Alzheimer's disease. | Mews MA et al. | β | 2025 | β |
| Brain multi-omic Mendelian randomisation to identify novel drug targets for gliomagenesis. | Thornton ZA et al. | β | 2025 | β |
| Cell state-dependent allelic effects and contextual Mendelian randomization analysis for human brain phenotypes. | Haglund A et al. | β | 2025 | β |
| Conventional and genetic association between migraine and stroke with druggable genome-wide Mendelian randomization. | Wang X et al. | β | 2025 | β |
| DriverOmicsNet: an integrated graph convolutional network for multi-omics exploration of cancer driver genes. | Dai YH et al. | β | 2025 | β |
| Drug repurposing candidates for amyotrophic lateral sclerosis using common and rare genetic variants. | Gerring ZF et al. | β | 2025 | β |
| Early establishment and life course stability of sex biases in the human brain transcriptome. | Benoit-Pilven C et al. | β | 2025 | β |
| From variants to mechanisms: Neurogenomics in the post-GWAS era. | Margolis MP et al. | β | 2025 | β |
| Genetically modeled GLP1R and GIPR agonism reduce binge drinking and alcohol-associated phenotypes: a multi-ancestry drug-target Mendelian randomization study. | Reitz J et al. | β | 2025 | β |
| Genetic determinants of monocyte splicing are enriched for disease susceptibility loci. | Nassiri I et al. | β | 2025 | β |
| Genetic inference of on-target and off-target side-effects of antipsychotic medications. | Elmore AR et al. | β | 2025 | β |
| Genetic Insights in Hindbrain Abnormalities Through Network Analysis Expose Key Biological Pathways in Hindbrain Development. | van Noort SAM et al. | β | 2025 | β |
| Genetic regulation of lncRNA expression in whole human brain and their contribution to CNS disorders. | He Y et al. | β | 2025 | β |
| Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. | Strom NI et al. | β | 2025 | β |
| Genome-wide association studies of Alzheimer's disease and related disorders stratified by sex, onset age, and Apolipoprotein E genotype reveal novel risk loci in African Americans. | Sherva R et al. | β | 2025 | β |
| Genome-wide epistasis analysis reveals significant epistatic signals associated with Parkinson's disease risk. | Cisterna-Garcia A et al. | β | 2025 | β |
| Genomic and GEO data integration identifies PDGFB as a potential therapeutic target for sepsis. | Guo M et al. | β | 2025 | β |
| HORNET: tools to find genes with causal evidence and their regulatory networks using eQTLs. | Lorincz-Comi N et al. | β | 2025 | β |
| Human mood disorder risk gene Synaptotagmin-14 contributes to mania-like behaviors in mice. | Zhang Y et al. | β | 2025 | β |
| Identification of 1q25.2 as a novel shared locus between schizophrenia and major depressive disorder in east Asians by integrative analyses. | Guo X et al. | β | 2025 | β |
| Identifying Causal Brain Structures, Genes, and Proteins for Osteoarthritis: A Large-Scale Genetic Correlation Study Based on Brain Imaging-Derived Phenotypes, Transcriptomes, and Proteomes. | Wang C et al. | β | 2025 | β |
| Immunological drivers and potential novel drug targets for major psychiatric, neurodevelopmental, and neurodegenerative conditions. | Dardani C et al. | β | 2025 | β |
| Inactivation of the SLC25A1 gene during embryogenesis induces a unique senescence program controlled by p53. | Kasprzyk-Pawelec A et al. | β | 2025 | β |
| Integrated genomic analysis and CRISPRi implicates <i>EGFR</i> in Alzheimer's disease risk. | Leung YY et al. | β | 2025 | β |
| Integrating axis quantitative trait loci looks beyond cell types and offers insights into brain-related traits. | Wang L et al. | β | 2025 | β |
| Integrating Genomic, eQTL, and Mendelian Randomization Analyses to Identify Microglial Drug Targets in Multiple Sclerosis. | Yan W et al. | β | 2025 | β |
| Integrating Multi-Omics Summary Data Identifies Candidate Molecular Mechanisms for Major Depression. | Nisbet L et al. | β | 2025 | β |
| Integrative genomics sheds light on the immunogenetics of tuberculosis in cattle. | O'Grady JF et al. | β | 2025 | β |
| Integrative multi-omics data from early development to identify the genes and cell types underlying attention-deficit/hyperactivity disorder. | Jiao S et al. | β | 2025 | β |
| Large-scale exome sequencing identified 18 novel genes for neuroticism in 394,005 UK-based individuals. | Wu XR et al. | β | 2025 | β |
| Leveraging pleiotropy for the improved treatment of psychiatric disorders. | Woodward DJ et al. | β | 2025 | β |
| Local genetic covariance analysis with lipid traits identifies novel loci for early-onset Alzheimer's Disease. | Ray NR et al. | β | 2025 | β |
| Massively parallel reporter assay investigates shared genetic variants of eight psychiatric disorders. | Lee S et al. | β | 2025 | β |
| Mendelian randomization identifies proteins involved in neurodegenerative diseases. | Belbasis L et al. | β | 2025 | β |
| Monocyte inflammation and resilience to Alzheimer's disease: novel genetic risk genes identified by transcriptome-wide association study. | Mustafa Y et al. | β | 2025 | β |
| Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's disease. | Rajabli F et al. | β | 2025 | β |
| Multiomic analyses direct hypotheses for Creutzfeldt-Jakob disease risk genes. | KΓΌΓ§ΓΌkali F et al. | β | 2025 | β |
| Multi-omics analysis for identifying cell-type-specific and bulk-level druggable targets in Alzheimer's disease. | Liu S et al. | β | 2025 | β |
| Novel early-onset Alzheimer-associated genes influence risk through dysregulation of glutamate, immune activation, and intracellular signaling pathways. | Bradley J et al. | β | 2025 | β |
| Role of expression quantitative trait loci (eQTL) in understanding genetic mechanisms underlying common complex diseases. | Hong SE et al. | β | 2025 | β |
| Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome. | Anand C et al. | β | 2025 | β |
| Shared genetics and causal relationship between sociability and the brain's default mode network. | Fanelli G et al. | β | 2025 | β |
| Spatially resolved mapping of cells associated with human complex traits. | Song L et al. | β | 2025 | β |
| The proteogenomic landscape of the human kidney and implications for cardio-kidney-metabolic health. | Hirohama D et al. | β | 2025 | β |
| The Psychiatric Genomics Consortium: discoveries and directions. | Agrawal A et al. | β | 2025 | β |
| Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies. | Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Electronic address: andrew.mcintosh@ed.ac.uk et al. | β | 2025 | β |
| Trends in Mendelian randomization in neurological disease research: a bibliometric analysis. | Yin S et al. | β | 2025 | β |
| Unveiling the genetic networks: Exploring the dynamic interaction of photosynthetic phenotypes in woody plants across varied light gradients. | Lu K et al. | β | 2025 | β |
| Whole-genome sequencing analyses suggest novel genetic factors associated with Alzheimer's disease and a cumulative effects model for risk liability. | Kim JP et al. | β | 2025 | β |
| A 3'UTR Insertion Is a Candidate Causal Variant at the <i>TMEM106B</i> Locus Associated With Increased Risk for FTLD-TDP. | Chemparathy A et al. | β | 2024 | β |
| A brief guide to analyzing expression quantitative trait loci. | Ko BS et al. | β | 2024 | β |
| A genetic and proteomic comparison of key AD biomarkers across tissues. | Marsh TW et al. | β | 2024 | β |
| A Genetic Bridge Between Medicine and Neurodiversity for Autism. | Leblond CS et al. | β | 2024 | β |
| A multi-ancestry cerebral cortex transcriptome-wide association study identifies genes associated with smoking behaviors. | Tan Q et al. | β | 2024 | β |
| An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer's Disease. | Zhang X et al. | β | 2024 | β |
| Assessing the Impact of PCSK9 and HMGCR Inhibition on Liver Function: Drug-Target Mendelian Randomization Analyses in Four Ancestries. | Rosoff DB et al. | β | 2024 | β |
| Brain cell-type shifts in Alzheimer's disease, autism, and schizophrenia interrogated using methylomics and genetics. | Yap CX et al. | β | 2024 | β |
| Brain tissue- and cell type-specific eQTL Mendelian randomization reveals efficacy of FADS1 and FADS2 on cognitive function. | Wu X et al. | β | 2024 | β |
| Cell-type deconvolution of bulk-blood RNA-seq reveals biological insights into neuropsychiatric disorders. | Boltz T et al. | β | 2024 | β |
| Cerebrospinal and Brain Proteins Implicated in Neuropsychiatric and Risk Factor Traits: Evidence from Mendelian Randomization. | de La Harpe R et al. | β | 2024 | β |
| Comprehensive analysis of genetic risk loci uncovers novel candidate genes and pathways in the comorbidity between depression and Alzheimer's disease. | Hofstra BM et al. | β | 2024 | β |
| Cross-ancestry analysis of brain QTLs enhances interpretation of schizophrenia genome-wide association studies. | Chen Y et al. | β | 2024 | β |
| Extensive co-regulation of neighboring genes complicates the use of eQTLs in target gene prioritization. | Tambets R et al. | β | 2024 | β |
| Eye-brain connections revealed by multimodal retinal and brain imaging genetics. | Zhao B et al. | β | 2024 | β |
| From genetic associations to genes: methods, applications, and challenges. | Qi T et al. | β | 2024 | β |
| Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal Phenotype. | Crayle JI et al. | β | 2024 | β |
| Genetic regulation of lncRNA expression in the whole human brain | He Y et al. | β | 2024 | β |
| Genetic risk factors underlying white matter hyperintensities and cortical atrophy. | Patel Y et al. | β | 2024 | β |
| Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesis. | AygΓΌn N et al. | β | 2024 | β |
| Genetic variants that modify neuroendocrine gene expression and foraging behavior of <i>C. elegans</i>. | Lee H et al. | β | 2024 | β |
| Genome-wide determinants of mortality and motor progression in Parkinson's disease. | Tan MMX et al. | β | 2024 | β |
| Genomic insights into the comorbidity between type 2 diabetes and schizophrenia. | Arruda AL et al. | β | 2024 | β |
| Identification of 27 allele-specific regulatory variants in Parkinson's disease using a massively parallel reporter assay. | Farrow SL et al. | β | 2024 | β |
| Identification of rare disease genes as drivers of common diseases through tissue-specific gene regulatory networks. | Bakker OB et al. | β | 2024 | β |
| Identification of shared genetic etiology of cardiovascular and cerebrovascular diseases through common cardiometabolic risk factors. | Ding K et al. | β | 2024 | β |
| Interaction molecular QTL mapping discovers cellular and environmental modifiers of genetic regulatory effects. | Kasela S et al. | β | 2024 | β |
| KnockoffHybrid: A knockoff framework for hybrid analysis of trio and population designs in genome-wide association studies. | Yang Y et al. | β | 2024 | β |
| Longitudinal change in memory performance as a strong endophenotype for Alzheimer's disease. | Archer DB et al. | β | 2024 | β |
| Multi-ancestry genome-wide association meta-analysis of Parkinson's disease. | Kim JJ et al. | β | 2024 | β |
| NEK4 modulates circadian fluctuations of emotional behaviors and synaptogenesis in male mice. | Yang ZH et al. | β | 2024 | β |
| Neurodevelopmental signature of a transcriptome-based polygenic risk score for depression. | Miles AE et al. | β | 2024 | β |
| Neuroimaging genomics as a window into the evolution of human sulcal organization. | Goltermann O et al. | β | 2024 | β |
| omicSynth: An open multi-omic community resource for identifying druggable targets across neurodegenerative diseases. | Alvarado CX et al. | β | 2024 | β |
| Pathway enrichment in genome-wide analysis of longitudinal Alzheimer's disease biomarker endophenotypes. | Rosewood TJ et al. | β | 2024 | β |
| PICALO: principal interaction component analysis for the identification of discrete technical, cell-type, and environmental factors that mediate eQTLs. | Vochteloo M et al. | β | 2024 | β |
| Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's disease. | Western D et al. | β | 2024 | β |
| Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease. | Wang L et al. | β | 2024 | β |
| Stimulating Wnt signaling reveals context-dependent genetic effects on gene regulation in primary human neural progenitors. | Matoba N et al. | β | 2024 | β |
| SUMMIT-FA: a new resource for improved transcriptome imputation using functional annotations. | Melton HJ et al. | β | 2024 | β |
| Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer's disease. | Qiu Y et al. | β | 2024 | β |
| Systems Genetics Analyses Reveals Key Genes Related to Behavioral Traits in the Striatum of CFW Mice. | Han Z et al. | β | 2024 | β |
| The Human Accelerated Region HAR202 Controls NPAS3 Expression in the Developing Forebrain Displaying Differential Enhancer Activity Between Modern and Archaic Human Sequences. | Caporale AL et al. | β | 2024 | β |
| Whole exome sequencing analyses identified novel genes for Alzheimer's disease and related dementia. | Zhang YR et al. | β | 2024 | β |
| Widespread transposable element dysregulation in human aging brains with Alzheimer's disease. | Feng Y et al. | β | 2024 | β |
| African ancestry GWAS of dementia in a large military cohort identifies significant risk loci. | Sherva R et al. | β | 2023 | β |
| Analysis of subcellular RNA fractions demonstrates significant genetic regulation of gene expression in human brain post-transcriptionally. | D'Sa K et al. | β | 2023 | β |
| Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. | de Klein N et al. | β | 2023 | β |
| Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease. | Martinez-Carrasco A et al. | β | 2023 | β |
| Genome-wide Analysis of Motor Progression in Parkinson Disease. | MartΓnez Carrasco A et al. | β | 2023 | β |
| GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture. | International League Against Epilepsy Consortium on Complex Epilepsies | β | 2023 | β |
| GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors. | Docherty AR et al. | β | 2023 | β |
| Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images. | Zhao B et al. | β | 2023 | β |
| Identification of circulating proteins associated with general cognitive function among middle-aged and older adults. | Tin A et al. | β | 2023 | β |
| Identification of genetic variants that impact gene co-expression relationships using large-scale single-cell data. | Li S et al. | β | 2023 | β |
| Inferring cell-type-specific causal gene regulatory networks during human neurogenesis. | AygΓΌn N et al. | β | 2023 | β |
| Mapping microRNA expression quantitative trait loci in the prenatal human brain implicates miR-1908-5p expression in bipolar disorder and other brain-related traits. | Toste CC et al. | β | 2023 | β |
| Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders. | Li X et al. | β | 2023 | β |
| Pathogenetic Insights into Developmental Coordination Disorder Reveal Substantial Overlap with Movement Disorders. | Garofalo M et al. | β | 2023 | β |
| Prediabetic HbA1c and Cortical Atrophy: Underlying Neurobiology. | Shin J et al. | β | 2023 | β |
| xQTLbiolinks: a comprehensive and scalable tool for integrative analysis of molecular QTLs. | Ding R et al. | β | 2023 | β |
| Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug-Target Mendelian Randomization Study. | Bell AS et al. | β | 2022 | β |
| Establishing gene regulatory networks from Parkinson's disease risk loci. | Farrow SL et al. | β | 2022 | β |
| Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study. | Zheng J et al. | β | 2022 | β |
| Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis. | Pistis G et al. | β | 2022 | β |
| Genetic Evidence for Protective Effects of Angiotensin-Converting Enzyme Against Alzheimer Disease But Not Other Neurodegenerative Diseases in European Populations. | Ryan DK et al. | β | 2022 | β |
| Genetic map of regional sulcal morphology in the human brain from UK biobank data. | Sun BB et al. | β | 2022 | β |
| Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder. | Reay WR et al. | β | 2022 | β |
| Genome-Wide Gene-Set Analysis Approaches in Amyotrophic Lateral Sclerosis. | Vasilopoulou C et al. | β | 2022 | β |
| Interpretation of the role of germline and somatic non-coding mutations in cancer: expression and chromatin conformation informed analysis. | Pudjihartono M et al. | β | 2022 | β |
| Advances in the genetic classification of amyotrophic lateral sclerosis. | Cooper-Knock J et al. | β | 2021 | β |
| A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. | Magusali N et al. | β | 2021 | β |
| Brain-trait-associated variants impact cell-type-specific gene regulation during neurogenesis. | AygΓΌn N et al. | β | 2021 | β |
| Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. | van Rheenen W et al. | β | 2021 | β |